Update on the immunological pathway of negative regulation in acute insults and sepsis

Journal of Interferon and Cytokine Research

Volumn 32, Issue 7, 2012, Pages 288-298

  Luan, Ying Yi ^a,b   Yao, Yong Ming ^a   Sheng, Zhi Yong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CD1D ANTIGEN; CD45RB ANTIGEN; CD45RO ANTIGEN; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR5; GAMMA INTERFERON; HEAT SHOCK PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 35; INTERLEUKIN 4; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 5; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; ZINC FINGER PROTEIN;

APOPTOSIS; AUTOIMMUNITY; BIOLOGICAL FUNCTIONS; BONE MARROW CELL; CD4 LYMPHOCYTE COUNT; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROTECTION; CYTOKINE RESPONSE; DENDRITIC CELL; DOWN REGULATION; GENE EXPRESSION; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; MULTIPLE SCLEROSIS; NATURAL KILLER T CELL; NEGATIVE FEEDBACK; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; SIGNAL TRANSDUCTION; SURVIVAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TH1 CELL; TH2 CELL; TISSUE INJURY;

HUMANS; MULTIPLE ORGAN FAILURE; SEPSIS; SIGNAL TRANSDUCTION;

EID: 84863795919     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0117     Document Type: Review

References (109)

1. Akdis M. 2006. Healthy immune response to allergens: TREGULATORY cells and more. Curr Opin Immunol 18(6):738-744.
2. Akdis M, Akdis CA. 2007. Mechanisms of allergen-specific immunotherapy.J Allergy Clin Immunol 119(4):780-791.
3. An H, Hou J, Zhou J, Zhao W, Xu H, Zheng Y, Yu Y, Liu S, Cao X.(2008) Phosphatase SHP-1 promotes TLR-and RIG-Iactivatedproduction of type I interferon by inhibiting thekinase IRAK1. Nat Immunol. 9(5)542-550.
4. Andrade CF, Waddell TK, Keshavjee S, Liu M. 2005. Innateimmunity and organ transplantation: The potential role of tolllikereceptors. Am J Transplant 5(5):969-975.
5. Asano M, Toda M, Sakaguchi N, Sakaguchi S. 1996. Autoimmunedisease as a consequence of developmental abnormalityof a T cell subpopulation. J Exp Med 184(2):387-396.
6. Bach JF. 2003. Regulatory T cells under scrutiny. Nat Rev Immunol3(3):189-198.
7. Baecher-Allan C, Viglietta V, Hafler DA. 2002. Inhibition of humanCD4+CD25+ high regulatory T cell function. J Immunol169(11):6210-6217.
8. Banchereau J, Steinman RM. 1998. Dendritic cells and the controlof immunity. Nature 392(6673):245-252.
9. Beetz S, Wesch D, Marischen L, Welte S, Oberg HH, Kabelitz D. 2008. Innate immune functions of human gammadelta T cells. Immunobiology 213(3-4):173-182.
10. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. 2002. CD4+CD25+ regulatory T cells control Leishmania majorpersistence and immunity. Nature 420(6915):502-507.
11. Bendelac A, Savage PB, Teyton L. 2007. The biology of NKT cells. Annu Rev Immunol 25:297-336.
12. Bidere N, Snow AL, Sakai K, Zheng L, Lenardo MJ. 2006. Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-kappaB activation. Curr Biol 16(16):1666-1671.
13. Blanco P, Viallard JF, Pellegrin JL, Moreau JF. 2005. Cytotoxic Tlymphocytes and autoimmunity. Curr Opin Rheumatol 17(6):731-734.
14. Boone DL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, Tsui C, Hurley P, Chien M, Chai S, Hitotsumatsu O, Mcnally E, Pickart C, Ma A. 2004. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. NatImmunol 5(10):1052-1060.
15. Bouaziz JD, Yanaba K, Tedder TF. 2008. Regulatory B cells as inhibitors of immune responses and inflammation. ImmunolRev 224:201-214.
16. Brigl M, Brenner MB. 2004. CD1: antigen presentation and T cellfunction. Annu Rev Immunol 22:817-890.
17. Cavassani KA, Carson WF, 4th, Moreira AP, Wen H, Schaller MA, Ishii M, Lindell DM, Dou Y, Lukacs NW, Keshamouni VG, Hogaboam CM, Kunkel SL. 2010. The post sepsisinducedexpansion and enhanced function of regulatory Tcells create an environment to potentiate tumor growth. Blood115(22):4403-4411.
18. Chaudhary PM, Eby MT, Jasmin A, Hood L. 1999. Activation of the c-Jun N-terminal kinase/stress-activated protein kinasepathway by overexpression of caspase-8 and its homologs. JBiol Chem 274(27):19211-19219.
19. Chen LC, Delgado JC, Jensen PE, Chen X. 2009. Direct expansionof human allospecific Foxp3+CD4+ regulatory T cells with allogeneicB cells for therapeutic application. J Immunol 183(6):4094-4102.
20. Chen Z, Laurence A, Kanno Y, Pacher-Zavisin M, Zhu BM, TatoC, Yoshimura A, Hennighausen L. 2006. Selective regulatoryfunction of SOCS3 in the formation of IL-17-secreting T cells.Proc Natl Acad Sci U S A 103(21):8137-8142.
21. Cherwinski HM, Schumacher JH, Brown KD, Mosmann TR.1987. Two types of mouse helper T cell clone. III. Furtherdifferences in lymphokine synthesis between Th1 and Th2clones revealed by RNA hybridization, functionally monospecificbioassays, and monoclonal antibodies. J Exp Med166(5):1229-1244.
22. Chuang TH, Ulevitch RJ. 2004. Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors. Nat Immunol 5(5):495-502.
23. Cohen J. 2002. The immunopathogenesis of sepsis. Nature 420(6917):885-891.
24. Croker BA, Kiu H, Nicholson SE. 2008. SOCS regulation of the JAK/STAT signalling pathway. Semin Cell Dev Biol 19(4): 414-422.
25. Daniel T, Thobe BM, Chaudry IH, Choudhry MA, Hubbard WJ, Schwacha MG. 2007. Regulation of the postburn wound inflammatory response by gammadelta T-cells. Shock 28(3): 278-283.
26. Davis BH, Zarev PV. 2005. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels. Cytometry B Clin Cytom 63(1):16-22.
27. Divanovic S, Trompette A, Atabani SF, Madan R, Golenbock DT, Visintin A, Finberg RW, Tarakhovsky A, Vogel SN, Belkaid Y, Kurt-Jones EA, Karp CL. 2005. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat Immunol 6(6):571-578.
28. Droste A, Sorg C, Hogger P. 1999. Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family. Biochem Biophys Res Commun 256(1): 110-113.
29. Ellis RJ. 1990. The molecular chaperone concept. Semin Cell Biol 1(1):1-9.
30. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Myazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387(6636):921-924.
31. Fink AL. 1999. Chaperone-mediated protein folding. Physiol Rev 79(2):425-449.
32. Freundt EC, Bidere N, Lenardo MJ. 2008. A different TIPE of immune homeostasis. Cell 133(3):401-402.
33. Fujimoto M, Tsutsui H, Yumikura-Futatsugi S, Ueda H, Xingshou O, Abe T, Kawase I, Nakanishi K, Kishimoto T, Naka T. 2002. A regulatory role for suppressor of cytokine signaling-1 in T(h) polarization in vivo. Int Immunol 14(11):1343-1350.
34. Fujita S, Seino K, Sato K, Sato Y, Eizumi K, Yamashita N, Taniguchi M, Sato K. 2006. Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response. Blood 107(9):3656-3664.
35. Fujita S, Yamashita N, Ishii Y, Sato Y, Sato K, Eizumi K, Fukaya T, Nozawa R, Takamoto Y, Yamashita N, Taniquchi M, SatoK. 2008. Regulatory dendritic cells protect against allergic airway inflammation in a murine asthmatic model. J AllergyClin Immunol 121(1):95-104.e7.
36. Gao Y, Yang W, Pan M, Scully E, Girardi M, Augenlicht LH, Craft J, Yin Z. 2003. Gamma delta T cells provide an early source of interferon gamma in tumor immunity. J Exp Med 198(3):433-442.
37. Gros MJ, Naquet P, Guinamard RR. 2008. Cell intrinsic TGF-beta 1 regulation of B cells. J Immunol 180(12):8153-8158.
38. Harris DP, Haynes L, Sayles PC, Duao DK, Eaton SM, Lepak NM, Johnson LL, Swain SL, Lund F. 2000. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 1(6):475-482.
39. Hesse M, Piccirillo CA, Belkaid Y, Prufer J, Mentink-Kane M, Leusink M, Cheever AW, Shevach EM, Wynn TA. 2004. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 172(5):3157-3166.
40. Hotchkiss RS, Karl IE. 2003. The pathophysiology and treatment of sepsis. N Engl J Med 348(2):138-150.
41. Huang LF, Yao YM, Dong N, Yu Y, He LX, Sheng ZY. 2010. Association between regulatory T cell activity and sepsis and outcome of severely burned patients: A prospective, observational study. Crit Care 14(1):R3.
42. Huang LF, Yao YM, Zhang LT,Dong N, Yu Y, Sheng ZY. 2009. The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats. Shock 31(3):322-329.
43. Iwasaka H, Noguchi T. 2004. [Th1/Th2 balance in systemic inflammatory response syndrome (SIRS)]. Nihon Rinsho 62(12): 2237-2243.
44. Korn T, Bettelli E, Oukka M, Kuchroo VK. 2009. IL-17 and Th17 Cells. Annu Rev Immunol 27:485-517.
45. Kushwah R, Wu J, Oliver JR, Jiang G, Zhang J, Siminovitch KA, Hu J. 2010. Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg. Eur J Immunol 40(4):1022-1035.
46. Larche M, Akdis CA, Valenta R. 2006. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 6(10):761-771.
47. Lemmers B, Salmena L, Bidere N, Su H, Matysiak-Zablocki E, Murakami K, Ohashi PS, Jurisicova A, Lenardo M, Hakem R,Hakem A. 2007. Essential role for caspase-8 in Toll-like receptorsand NFkappaB signaling. J Biol Chem 282(10):7416-7423.
48. Li D, Song L, Fan Y, Li X, Li Y, Chen J, Zhu F, Guo C, Shi Y, Zhang L. 2009. Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Immunol 133(3):422-427.
49. Lindquist S, Craig EA. 1988. The heat-shock proteins. Annu Rev Genet 22:631-677.
50. Liu QY, Yao YM, Zhang SW, Yan YH, Wu X. 2011. Naturally existing CD11clowCD45RBhigh dendritic cells protect mice from acute severe inflammatory response induced by thermal injury. Immunobiology 216(1-2):47-53.
51. Luan YY, Yao YM, Zhang L, Dong N, Zhang QH, Yu Y, Sheng ZY. 2011. Expression of tumor necrosis factor-a induced protein 8 like-2 contributes to the immunosuppressive property of CD4+CD25+ regulatory T cells in mice. Mol Immunol 49(1-2):219-226.
52. Lund FE, Randall TD. 2010. Effector and regulatory B cells: Modulators of CD4+ T cell immunity. Nat Rev Immunol 10(4):236-247.
53. MacConmara MP, Maung AA, Fujimi S, McKenna AM, Delisle A, Lapchak PH, Rogers S, Lederer JA, Mannick JA. 2006. Increased CD4+CD25+T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann Surg 244(4): 514-523.
54. Malhotra V, Wong HR. 2002. Interactions between the heat shock response and the nuclear factor-kappa B signaling pathway. Crit Care Med 30(1 Suppl):S89-S95.
55. Mann MK, Maresz K, Shriver LP, Tan Y, Dittel BN. 2007. B cell regulation of CD4+CD25+T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J Immunol 178(6):3447-3456.
56. McConnell KW, Fox AC, Clark AT, Chang NYN, Dominguez JA, Farris AB, Buchman TG, Hunt C, Coopersmith CM. 2011. The role of heat shock protein 70 in mediating age-dependent mortality in sepsis. J Immunol 186(6):3718-3725.
57. Mellor AL, Baban B, Chandler PR, Manlapat A, Kahler DJ, MunnDH. 2005. Cutting edge: Cpg oligonucleotides induce splenic CD19 + dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. J Immunol 175(9):5601-5605.
58. Mombaerts P, Arnoldi J, Russ F, Tonegawa S, Kaufmann SH. 1993. Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen. Nature 365(6441):53-56.
59. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765.
60. Moore TA, Moore BB, Newstead MW, Standiford TJ. 2000. Gamma delta-T cells are critical for survival and early proinflammatory cytokine gene expression during murine Klebsiella pneumonia. J Immunol 165(5):2643-2650.
61. Mosmann TR, Coffman RL. 1989. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173.
62. Murphy JE, Tedbury PR, Homer-Vanniasinkam S, Walker JH, Ponnambalam S. 2005. Biochemistry and cell biology ofmammalian scavenger receptors. Atherosclerosis 182(1):1-15.
63. Naka T, Narazaki M, Hirata M, Matsumoto T, Minatoto S, Aono A, Nishimoto N, Taga T, Yoshizaki K, Akira S. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature387(6636):924-929.
64. Ochs HD, Oukka M, Torgerson TR. 2009. TH17 cells and regulatory T cells in primary immunodeficiency diseases. J Allergy Clin Immunol 123(5):977-983; quiz 984-985.
65. Onofre G, Kolackova M, Jankovicova K, Krejsek J. 2009. Scavenger receptor CD163 and its biological functions. Acta Medica (Hradec Kralove) 52(2):57-61.
66. Parekh VV, Lalani S, Van Kaer L. 2007. The in vivo response of invariant natural killer T cells to glycolipid antigens. Int RevImmunol 26(1-2):31-48.
67. Pastille E, Didovic S, Brauckmann D, Rani M, Agrawal H, Schade FU, Zhang Y, Flohe SB. 2011. Modulation of dendritic cell differentiation in the bone marrow mediates sustained immunosuppression after polymicrobial sepsis. J Immunol 186(2):977-986.
68. Pluddemann A, Neyen C, Gordon S. 2007. Macrophage scavenger receptors and host-derived ligands. Methods 43(3):207-217.
69. Polfliet MM, Fabriek BO, Daniels WP, Dijkstra CD, van den Berg TK. 2006. The rat macrophage scavenger receptor CD163: expression, regulation and role in inflammatory mediator production. Immunobiology 211(6-8):419-425.
70. Prasad AS. 2007. Zinc: Mechanisms of host defense. J Nutr 137(5):1345-1349.
71. Ranges GE, Figari IS, Espevik T, Palladino MA, Jr. 1987. Inhibition of cytotoxic T cell development by transforminggrowth factor beta and reversal by recombinant tumor necrosisfactor alpha. J Exp Med 166(4):991-998.
72. Rao PE, Petrone AL, Ponath PD. 2005. Differentiation andexpansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-{beta}. J Immunol 174(3):1446-1455.
73. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of asingle mechanism of self-tolerance causes various autoimmunediseases. J Immunol 155(3):1151-1164.
74. Sakaguchi S, Setoguchi R, Yagi H, Nomura T. 2006. Naturallyarising Foxp3-expressing CD25+CD4+ regulatory T cells inself-tolerance and autoimmune disease. Curr Top MicrobiolImmunol 305:51-66.
75. Schaaf B, Luitjens K, Goldmann T, van Bremen T, Sayk F, Dodt C, Dalhoff K, Droemann D. 2009. Mortality in human sepsis isassociated with downregulation of Toll-like receptor 2 andCD14 expression on blood monocytes. Diagn Pathol 4:12.
76. Schwacha MG, Ayala A, Chaudry IH. 2000. Insights into the roleof gammadelta T lymphocytes in the immunopathogenic responseto thermal injury. J Leukoc Biol 67(5):644-650.
77. Shah S, Qiao L. 2008. Resting B cells expand a CD4+CD25+Foxp3+Treg population via TGF-beta3. Eur J Immunol 38(9):2488-2498.
78. Shevach EM. 2002. CD4 + CD25 + suppressor T cells: Morequestions than answers. Nat Rev Immunol 2(6):389-400.
79. Sibilia J. 2004. Novel concepts and treatments for autoimmunedisease: Ten focal points. Joint Bone Spine 71(6):511-517.
80. Starr R, Willson TA, Viney EM, Murray LL, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA. 1997.a family of cytokine-inducible inhibitors of signalling. Nature 387(6636):917-921.
81. Steinman RM, Banchereau J. 2007. Taking dendritic cells into medicine. Nature 449(7161):419-426.
82. Sun H, Gong S, Carmody RJ, Hilliard A, Li L, Sun J, Kong L, Xu L, Hilliard B, Hu S, Shen H, Yang X, Chen YH. 2008a. TIPE2, anegative regulator of innate and adaptive immunity thatmaintains immune homeostasis. Cell 133(3):415-426.
83. Sun JB, Flach CF, Czerkinsky C, Holmgren J. 2008b. B lymphocytes promote expansion of regulatory T cells in oral tolerance: Powerful induction by antigen coupled to cholera toxin B subunit. J Immunol 181(12):8278-8287.
84. Sun SC. 2008. Deubiquitylation and regulation of the immune response. Nat Rev Immunol 8(7):501-511.
85. Suri-Payer E, Amar AZ, Thornton AM, Shevach EM. 1998.CD4+CD25+T cells inhibit both the induction and effectorfunction of autoreactive T cells and represent a unique lineageof immunoregulatory cells. J Immunol 160(3):1212-1218.
86. Takahashi K, Kawai T, Kumar H, Sato S, Yonehara S, Akira S.2006. Roles of caspase-8 and caspase-10 in innate immune responses to double-stranded RNA. J Immunol 176(8):4520-4524.
87. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H. 2003.The regulatory role of Valpha14 NKT cells in innate andacquired immune response. Annu Rev Immunol 21:483-513.
88. Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL. 2001.Lipopolysaccharide-activated B cells down-regulate Th1 immunityand prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 167(2):1081-1089.
89. Toth B, Alexander M, Daniel T, Chaudry IH, Hubbard WJ, Schwacha MG. 2004. The role of gammadelta T cells in the regulation of neutrophil-mediated tissue damage after thermal injury. J Leukoc Biol 76(3):545-552.
90. Tough DF, Sprent J. 1998. Lifespan of gamma/delta T cells. J Exp Med 187(3):357-365.
91. Tu W, Lau YL, Zheng J, Liu Y, Chan PL, Mao H, Dionis K, Schneider P, Lewis DB. 2008. Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells. Blood 112(6):2554-2562.
92. van PL, Perez VL, Abbas AK. 1998. Mechanisms of peripheral T cell tolerance. Novartis Found Symp 215:5-14; discussion14-20, 33-40.
93. Van Kaer L. 2004. Regulation of immune responses by CD1drestricted natural killer T cells. Immunol Res 30(2):139-153.
94. Venet F, Pachot A, Debard AL, Bohe J, Bienvenu J, Lepape A, Powell WS, Monneret G. 2006. Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J Immunol 177(9):6540-6547.
95. Verstrepen L, Verhelst K, van LG, Carpentier I, Ley SC, Beyaert R. 2010. Expression, biological activities and mechanisms of action of A20 (TNFAIP3). Biochem Pharmacol 80(12):2009-2020.
96. Wakkach A, Cottrez F, Groux H. 2001. Differentiation of regulatory T cells 1 is induced by CD2 costimulation. J Immunol 167(6):3107-3113.
97. Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H. 2003. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18(5):605-617.
98. Wang J, Hu Y, Deng WW, Sun B. 2009. Negative regulation of Toll-like receptor signaling pathway. Microbes Infect 11(3): 321-327.
99. Wieten L, Broere F, der Zee R v, Koerkamp EK, Wagenaar J, van EW. 2007. Cell stress induced HSP are targets of regulatory T cells: A role for HSP inducing compounds as anti-inflammatory immuno-modulators. FEBS Lett 581(19): 3716-3722.
100. Wu L, Gabriel CL, Parekh VV, Van Kaer L. 2009. Invariant natural killer T cells: Innate-like T cells with potent immunomodulatory activities. Tissue Antigens 73(6):535-545.
101. Xi W, Hu Y, Liu Y, Zhang J, Wang L, Lou Y, Qu Z, Cui J, Zhang G, Liang X, Ma C, Gao C, Chen Y, Liu S. 2011. Roles of TIPE2 in hepatitis B virus-induced hepatic inflammation in humans and mice. Mol Immunol 48(9-10):1203-1208.
102. Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA. 2001. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol 166(12):7282-7289.
103. Yao YM, Redl H, Bahrami S, Schlag G. 1998. The inflammatory basis of trauma/shock-associated multiple organ failure. Inflamm Res 47(5):201-210.
104. Yao YM, Sheng ZY, Huang LF. 2009. The effect of a novel cytokine, high mobility group box 1 protein, on the development of traumatic sepsis. Chin J Integr Med 15(1):13-15.
105. Yi H, Zhen Y, Jiang L, Zheng J, Zhao Y. 2006. The phenotypic characterization of naturally occurring regulatory CD4+ CD25+T cells. Cell Mol Immunol 3(3):189-195.
106. Zhang L, Shi Y, Wang Y, Zhu F, Wang Q, Ma C, Chen YH, Zhang L. 2011. The unique expression profile of human TIPE2 suggests new functions beyond its role in immune regulation. Mol Immunol 48(9-10):1209-1215.
107. Zhang X, Wang J, Fan C, Li H, Sun H, Gong S, Chen YH, Shi Y. 2009. Crystal structure of TIPE2 provides insights into immune homeostasis. Nat Struct Mol Biol 16(1):89-90.
108. Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA. 2002. Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25-precursors. J Immunol 169(8):4183-4189.
109. Zou W. 2006. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6(4):295-307.